Literature DB >> 24595492

Histopathological evidence of invasive gastric mucormycosis after transarterial chemoembolization and liver transplantation.

P Kaiser1, E M Maggio, T Pfammatter, B Misselwitz, S Flury, P M Schneider, P Dutkowski, S Breitenstein, B Müllhaupt, P A Clavien, N J Mueller.   

Abstract

We describe a case of a 62-year-old diabetic woman with hepatocellular carcinoma due to chronic hepatitis B virus infection. Two weeks after orthotopic liver transplantation, endoscopy for massive upper gastrointestinal bleeding revealed a large necrotic area in the gastric fundus. The patient underwent emergency resection. Histopathologically, angioinvasive mold infection compatible with mucormycosis was diagnosed in a large area of necrosis, mimicking an atypically localized gastric ulcer. Foreign bodies originating from transarterial chemoembolization (TACE) performed 7 and 8 months earlier and 40 days before transplantation were identified in the submucosal tissue. The patient was treated with liposomal amphotericin B (LAB) for 5 weeks, followed by 7 weeks of posaconazole. Follow-up biopsies after 1 and 5 months confirmed successful treatment. Review of the radiological images of the TACE procedure showed that some of the TACE material had been diverted to the stomach via an accessory gastric branch originating from the left hepatic artery. TACE agents may be associated with chronic, refractory gastroduodenal ulcers. We hypothesize that the ischemic lesion was first colonized with presumed Mucorales mold and invasive growth was promoted by the posttransplantation immunosuppression. Careful exploration of extrahepatic collaterals during TACE may prevent this complication.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595492     DOI: 10.1007/s15010-014-0603-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Nontarget embolization complicating transarterial chemoembolization in a patient with hepatocellular carcinoma.

Authors:  Christopher R Ingraham; Guy E Johnson; Ajit V Nair; Siddharth A Padia
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  How does antifungal pharmacology differ for mucormycosis versus aspergillosis?

Authors:  Russell E Lewis; Olivier Lortholary; Brad Spellberg; Emmanuel Roilides; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 3.  Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives.

Authors:  Kyung J Kwon-Chung
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Authors:  Peter G Pappas; Barbara D Alexander; David R Andes; Susan Hadley; Carol A Kauffman; Alison Freifeld; Elias J Anaissie; Lisa M Brumble; Loreen Herwaldt; James Ito; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren A Marr; Vicki A Morrison; Benjamin J Park; Thomas F Patterson; Trish M Perl; Robert A Oster; Mindy G Schuster; Randall Walker; Thomas J Walsh; Kathleen A Wannemuehler; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

5.  The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus.

Authors:  Arunaloke Chakrabarti; Ashim Das; Jharna Mandal; M R Shivaprakash; Varghese K George; Bansidhar Tarai; Pooja Rao; Naresh Panda; Subhash C Verma; Vinay Sakhuja
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

6.  Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: a retrospective study of 280 cases.

Authors:  Ting-Kai Leung; Chi-Ming Lee; Hsin-Chi Chen
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

7.  Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.

Authors:  Ashraf S Ibrahim; Valentina Avanessian; Brad Spellberg; John E Edwards
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 8.  Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

Authors:  Anna Skiada; Fanny Lanternier; Andreas H Groll; Livio Pagano; Stephan Zimmerli; Raoul Herbrecht; Olivier Lortholary; George L Petrikkos
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

9.  Gastrointestinal mucormycosis.

Authors:  S R Thomson; P G Bade; M Taams; V Chrystal
Journal:  Br J Surg       Date:  1991-08       Impact factor: 6.939

10.  Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

Authors:  Caitlin Reed; Richard Bryant; Ashraf S Ibrahim; John Edwards; Scott G Filler; Robert Goldberg; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

View more
  2 in total

Review 1.  Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.

Authors:  Tomohisa Uchida; Momoko Okamoto; Keita Fujikawa; Daisuke Yoshikawa; Akinari Mizokami; Tomo Mihara; Akira Kondo; Kazuo Ohba; Kazuhiro Kurohama; Masahiro Nakashima; Ichiro Sekine; Shigeki Nakamura; Yoshitsugu Miyazaki; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

2.  Idiopathic gastric fundus necrosis: Case report about a rare and fatal clinical condition.

Authors:  Valeria Tognoni; Carlo Gazia; Anton Mariani Ivanikhin; Cristine Pathirannehalage Don; Dario Venditti
Journal:  Int J Surg Case Rep       Date:  2020-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.